NP22657 TC Support eBook 2024-01-29 - Flipbook - Page 20
Research investment and leadership to
expand access and improve outcomes
CIBMTR
“The strength of the
CIBMTR lies in our
collaboration with
transplant centers
around the world and
their commitment to
advancing cell therapy
for the patients we
all serve. Research
conducted through
the CIBMTR has led
to innovations and
practice change so
patients not only
survive but thrive.”
—Jeff Auletta, MD
Chief Scienti昀椀c Director
CIBMTR NMDP
In partnership with centers around the world, we lead
transformative research and outcomes analysis through the
CIBMTR—a research collaboration between Medical College
of Wisconsin and NMDP—to help you make data-driven
clinical decisions.
Through the collaboration and dedication of our transplant
center partners, we collect outcomes data on:
• Every allogeneic transplant performed in the U ⸀S ⸀
• U ⸀S ⸀ autologous transplants with data voluntarily submitted
by transplant centers
• International allogeneic and autologous transplants with data
voluntarily submitted by transplant centers
• Other cell therapies, including commercial cell therapy
products for hematologic indications
The CIBMTR’s clinical database contains information from
more than 630,000 patients ⸀ It can be used for patient care
decisions, developing research studies, education and CIBMTR
research studies ⸀ The database is a critical tool to improve
patient outcomes ⸀
BMT CTN
More than 100 of our transplant center partners participate
in the Blood and Marrow Transplant Clinical Trials Network
(BMT CTN) ⸀ Through the BMT CTN, we conduct large, multiinstitutional Phase II and Phase III clinical trials that are available
to patients in all regions of the U ⸀S ⸀
CIBMTR CRO SERVICES
Our CIBMTR CRO Services team specializes in the design and
oversight of transplant and cell therapy clinical trials ⸀ CIBMTR
CRO Services focuses on collaboration with organizations on
the highest impact clinical trials ⸀
20